Pharma Stocks
-
Aurobindo Pharma Ltd. Technical Momentum Shifts Amid Side…
Technical Trend Overview Recent analysis indicates that Aurobindo Pharma’s technical trend has softened from mildly bullish to sideways, signalling a…
Read More » -
SENSEX tanks 2,354 pts, NIFTY50 below 24,600 in noon deals; Pharma shares, MCX among buzzing stocks
The Indian benchmark indices, SENSEX and NIFTY50, were trading in deep red during the afternoon session on Sunday, February 1,…
Read More » -
Ajanta Pharma Ltd. Technical Momentum Shifts Signal Bulli…
Technical Trend Evolution and Price Momentum Ajanta Pharma’s technical trend has transitioned from mildly bullish to outright bullish, underscoring a…
Read More » -
Is Mirum Pharmaceuticals on a Strong Path to Profitability?
Mirum Pharmaceuticals (NASDAQ: MIRM), a mid-cap biotech, performed well last year and is maintaining that momentum so far in 2026.…
Read More » -
Sun Pharma Q3 Results: Cons PAT jumps 16% YoY to Rs 3,369 crore; Rs 11/share interim dividend declared
Pharma major Sun Pharmaceuticals on Saturday reported a consolidated net profit of Rs 3,369 crore in the third quarter of…
Read More » -
Stocks To Watch On February 1: Bajaj Auto, BoB, Sun Pharma, SAIL, IDFC First Bank and more
1 / 11 SAIL | The company reported a Q3 net profit of ₹374 crore, revenue of ₹27,371 crore and…
Read More » -
Gland Pharma Limited Just Beat Earnings Expectations: Here’s What Analysts Think Will Happen Next
A week ago, Gland Pharma Limited (NSE:GLAND) came out with a strong set of quarterly numbers that could potentially lead…
Read More » -
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
China SXT Pharmaceuticals, Inc. TAIZHOU, China, Jan. 30, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceutics, Inc. (Nasdaq: SXTC) (the “Company”…
Read More » -
Aurobindo Pharma Sees Significant Open Interest Surge Ami…
Open Interest Spike and Volume Dynamics On 30 Jan 2026, Aurobindo Pharma’s open interest (OI) in derivatives rose sharply by…
Read More » -
JCR Pharmaceuticals (TSE:4552) Q3 EPS Slide Challenges Bullish Profit Recovery Narrative
JCR Pharmaceuticals (TSE:4552) has reported Q3 2026 revenue of ¥8,991 million and basic EPS of ¥0.28, alongside net income excluding…
Read More »